<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2018</YEAR>
<VOL>22</VOL>
<NO>3</NO>
<MOSALSAL>70</MOSALSAL>
<PAGE_NO>212</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF> Diabetes mellitus linked Alzheimer’s disease – A review on sporadic form of Alzheimer’s disease</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>This review mainly deals with scientific data related to sporadic Alzheimer&#8217;s disease (AD) particularly related to diabetes mellitus (DM). AD is divided into sporadic AD and familial AD. It is known to be the most common cause of dementia. Sporadic form of AD results from multiple etiologic factors including metabolic, environmental and genetic factors. DM linked AD is known to be one of major challenges to health care system in these days. Both type 1 and type 2 DM is strongly related to cognitive impairment and known to be a major risk factor in the development of probable Alzheimer&#8217;s disease. In this review, the various mechanisms involved in the development of neuronal degeneration associated with chronic hyperglycaemia are discussed.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>141</FPAGE>
			<TPAGE>145</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/11
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/10/21
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/20
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/6/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Ramu</Name>
				<MidName></MidName>
				<Family>Sathiya</Family>
				<NameE>Ramu</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sathiya</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>sathiya.pg.ph@msruas.ac.in</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Anita</Name>
				<MidName></MidName>
				<Family>Murali</Family>
				<NameE>Anita</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Murali</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>anitamurali.pg.ph@msruas.ac.in</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Jayaraman</Name>
				<MidName></MidName>
				<Family>Anbu</Family>
				<NameE>Jayaraman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Anbu</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>anbu.pg.ph@msruas.ac.in</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Diabetes mellitus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Alzheimer’s disease</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hyperglycemia</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Ariza L, Pages G, Garcia-Lareu B, Cobianchi S, Otaegui j, Ruberte J et al. Experimental diabetes in neonatal mice induces early peripheral sensorimotor neuropathy. Neurosci. 2014;274:250-259.##Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res. 1991;539 (1):11–18.##Belluti F, Rampa A, Gobbi S, Bisi A. Small-molecule inhibitors/ Modulators of amyloid-beta peptide aggregation and toxicity for the treatment of Alzheimer’s disease, a patent review, Expert Opin Ther Pat. 2013;23(5):581–96.##Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens PC. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.##Bigl M, Apelt J, Eschrich K, Schliebs R. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology. J Neural Transm. 2003;110:77.##Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid β-peptide. Trends in Mol Med. 2001;7(12):548–554##Castegna A, Michael AM, Marina A, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in alzheimer’s disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Rad Biol Med. 2002;33(4):562–571##Connor B, Beilharz EJ, Williams C, Synek B, Gluckman PD, Faull RLM, Dragunow M. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus (Short communication). Mol Brain Res. 1997;49(1–2):283–290##Diwan A, Khan SA, Patel R, Krishna K, Firoz CK, Kamal MA. Spectrum from obesity to neurodegenerative disorder. Am J Neuroprot Neuroregen. 2012;4 (1):31–39.##Duarte JMN, Oses JP, Rodrigues RJ, Cunha RA. Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats. Neurosci. 2007;149(2); 382-391.##Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ. Hyperinsulinism in infancy: From basic science to clinical disease. Physiol Rev. 2004;84:239.##Freude S, Schilbach K, Schubert M. The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimer's disease: From Model Organisms to Human Disease. Current Alzheimer Res. 2009;6 (3):213-223.##Ghanemi A. Alzheimer’s disease therapies, selected advances and future perspectives. Alexandria J Med. 2005;51(1):1-3.##Gong CX, Grundke-Iqbal I, Iqbal K. Targeting tau protein in Alzheimer's disease. Drugs Aging. 2010;27(5):351-65. ## Goss JR, Finch CE, Morgan DG. Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging. 1991;12(2):165–170.##Hanuman T, Allam AR, Kiran KR, Sivaprasad A, Suresh BC, Gedela S. Alzheimer’s disease care and management: role of information technology. Bioinform. 2007;2:91–95.##Hooijmans CR, Graven C, Dederen PJ, Tanila H, Groen T, Kiliaan AJ. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res. 2007;1181: 93.##Hoyer S. Brain glucose and energy metabolism during normal aging. Aging (Milano). 1990;2:245.##Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabet. 2004;53:474.##Jolivalt CG, Calcutt NA, Masliah E. Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and alzheimer’s disease. Neurosci. 2012;202:405–412.##Kamboj S, Chopra K, Sandhir R. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes, beneficial effect of N-acetylcysteine Supplementation. Neurosci. 2009;162:349–358.##Kodl CT, Seaquist CR. Cognitive dysfunction and diabetes mellitus 1. Endocr Rev. 2008;29:494.##Korolainen MA, Auriola S, Nyman TA, Alafuzoff I, TuulaPirttilä T. Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain. Neurobiol Dis. 2005;20(3):858–870.##Li L, Zhang Z, Holscher C, Gao C, Jiang Y, Liu Y. (Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocinin Rat brains, Eur J. Pharmacol. 2012;674:280–286.##Li N, Zhou L, Li W, Liu Y, Wang J, He P. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: A metabolomics study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;15:54-61.##Liu J, Feng L, Zhang M, Ma D, Wang S, Fu Q, Ma S. Neuroprotective effect of LiuweiDihuang decoction on cognition deﬁcits of diabetic encephalopathy in streptozotocin-induced diabetic rat, J Ethnopharmacol. 2013;150:371–381.##Liu Y, Xie L, Liu H, Yang J, Wang G, Liu X, Lu S, Wen T. Increased amyloid β peptide (1–40) level in brain of Streptozotocin-induced diabetic rats. Neurosci. 2008;153:796–802.##Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s disease. Neurobiol Aging. 1997;18(5):457–461.##Madasamy S, Chaudhuri V, Kong R, Alderete B, Adams CM, Knaak TD, Ruan W, Alan HB, Wu, Bigos M, Amento EP. Plaque array method and proteomics-based identification of biomarkers from Alzheimer's disease serum. Clin Chim Acta. 2015;441(20):79-85.##Morabito MV, Berman DE, Schneider RT, Zhang Y, Leibel RL, Small SA. Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease. Neurobiol. Dis. 2014;65:188-192.##Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, et al. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging. 2008;29:676.##Mount C, Downton C. Alzheimer disease: progress or proﬁt. Nat Med. 2006;12:780–4.##Mushtaq G, Jalaluddin AK, Kumosani TA, Kamal MA. Alzheimer’s disease and type 2 diabetes via chronic inﬂammatory mechanisms. Saudi J Biol Sci. 2015;22:4–13.##O'Neill C, Kiel AP, Coakley MF, Manning S, Long-Smith CM. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochem Soc Trans. 2012;40(4):721-7.##Peraldi P, Spiegelman BM. Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-alpha. J Endocrinol. 1997;155:219–220.##Porat Y, Kolusheva S, Jelinek R, Gazit E. The human islet amyloid polypeptide forms transient membrane-active preﬁbrillar assemblies. Biochemistry 2003;42:10971.##Rahigude A, Bhutada P, Kaulaskar S, Aswar M, otari K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neurosci. 2012;226:62-72.##Reddy VP, Obrenovich ME, Atwood CS, Perry G, Smith MA.  Involvement of Maillard reactions in Alzheimer disease. Neurotox Res. 2001; 4: 191.##Richardson JTE. Cognitive function in diabetes-mellitus. Neurosci Biobehav Rev. 1990;14:385.##Saido TC. Metabolism of Aβ peptide and pathogenesis of AD(2010–2012). Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(7):321–39.##Sasaki-Hamada S, Sacai H, Oka JI. Diabetes onset influences hippocampal synaptic Plasticity in streptozotocin-treated rats, Neurosci. 201;227:293–304.##Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci. 2000;97:6037.##Smith MA, Sayre LM, Monnier VM, Perry G. Radical Aging in Alzheimer's disease. Trends Neurosci. 1995;18:172.##Soares IE, Prediger S, Nunes S, Castro AA, Viana SD, Lemos C et al. Spatial memory impairments in a prediabetic rat model. Neurosci. 2013;250(10):565-577.##Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 1999;16:93–112.##Strachan MW, Deary IJ, Ewing, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabet Care. 1997;20:438.##Sun X, Bromley-Brits K, Song W. Regulation of beta-site APP cleaving enzyme 1 gene expression and its role in Alzheimer’s disease. J Neurochem. 2012;120(1):62–70.##Tun PA, Nathan DM, Perlmuter LC. Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med. 1990;6:731.##Valla J, Gonzalez-Lima F, Reiman EM. FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int J Dev Neurosci. 2008;26:253.##WHO (2012) media centre: diabetes fact sheet available at http:// www.who.int/mediacentre/factsheets/fs312/en/.##Williams T, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging. 2006;27(8):1094–1099.##Wurtman R. Biomarkers in the diagnosis and management of Alzheimer’s disease. Metabolism 2015;3(1):47-50.##Yang Y, Song W. Molecular links between Alzheimer’s disease and diabetes mellitus. Neuroscience 2013;250:140–150.##Zhao Q, Townsend M. Insulin receptor in cognition. Biochim Biophys Acta 2009;1792: 482–496.##Zhao W, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease, Biochimica et Biophysica Acta 2009;1792:482–496.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Urban traffic noise pollution disturbs spatial learning and memory and increases anxiety-like behavior in adult male rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Noise pollution is an unwanted inevitable distribution of the modern and industrialized life of mankind. With the expansion of urban life, humans are daily exposed to noise pollution which can cause anxiety and disorders in cognitive activities. The present study was aimed to investigate the impact of sub-chronic urban traffic noise pollution on learning, memory and anxiety-like behavior in adult male rats. Methods: Thirty two adult male Wistar rats (weighing 275-300g) were used in the present experimental study. The animals were divided into two groups: the control and the noise-exposed. The rats in the test group were exposed to a 90dB noise recorded from a crowded street traffic for 6h/10 days. Control rats were intact. Morris water maze (MWM) and an elevated plus maze (EPM) were used to assess spatial learning and memory and anxiety-like behavior in rats. Results: The findings displayed that both control and noise-exposed group improved their maze steering over 4 days of experiment in MWM; however, noise-exposed group had more latency and traveled-distance in MWM to find the hidden platform in probe trial compared to those of control (P&#60;0.05). Moreover, noise-exposed group showed a significant increase in weight gain compared to the control group (P&#60;0.05). In addition, the spent time in open arm of the EPM was significantly decreased compared to controls (P&#60;0.05). Conclusion: Urban traffic noise pollution for a short-term period causes a meaningful increase on weight gain, disorders in retrieval memory and increase in anxiety-like behavior in rats.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>146</FPAGE>
			<TPAGE>154</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/10
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/11/21
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/20
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/5/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Mohammad Reza</Name>
				<MidName></MidName>
				<Family>Afarinesh</Family>
				<NameE>Mohammad Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Afarinesh</FamilyE>
				<Organizations>
				<Organization>Kerman Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>r.afarinesh@kmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Baharak</Name>
				<MidName></MidName>
				<Family>Akhtardanesh</Family>
				<NameE>Baharak</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akhtardanesh</FamilyE>
				<Organizations>
				<Organization>Clinical Science Department, Veterinary Faculty, Shahid Bahonar University, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>B.akhtardanesh@mail.uk.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Tahereh</Name>
				<MidName></MidName>
				<Family>Haghpanah</Family>
				<NameE>Tahereh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Haghpanah</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>t.haghpah@kmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Golshan</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Golshan</FamilyE>
				<Organizations>
				<Organization>Kerman Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>faly.golshan@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Gholam Hossein</Name>
				<MidName></MidName>
				<Family>Meftahi</Family>
				<NameE>Gholam Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Meftahi</FamilyE>
				<Organizations>
				<Organization>Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>hossein.meftahi@bmsu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Niousha</Name>
				<MidName></MidName>
				<Family>Ghanbarpour</Family>
				<NameE>Niousha</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghanbarpour</FamilyE>
				<Organizations>
				<Organization>National Organization for Development of Exceptional Talents, School For Gifted Students, Education Department, Part 1</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>N.ghanbarpour@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ayoob</Name>
				<MidName></MidName>
				<Family>Fakhri</Family>
				<NameE>Ayoob</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fakhri</FamilyE>
				<Organizations>
				<Organization>Clinical Science Department, Veterinary Faculty, Shahid Bahonar University, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>ayoobfakhri@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Saeed</Name>
				<MidName></MidName>
				<Family>Sheikhshoaei</Family>
				<NameE>Saeed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sheikhshoaei</FamilyE>
				<Organizations>
				<Organization>Kerman Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>shoaeesaeed@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Vahid</Name>
				<MidName></MidName>
				<Family>Sheibani</Family>
				<NameE>Vahid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sheibani</FamilyE>
				<Organizations>
				<Organization>Kerman Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>v.sheibani@kmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Noise pollution</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Learning</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Anxiety</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Male rats</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Babisch W. Stress hormones in the research on cardiovascular effects of noise. Noise Health 2003; 5: 1-11.##Badache S, Bouslama S, Brahmia O, Bairi AM, Tahraoui AK, Ladjama A. Prenatal noise and restraint stress interact to alter exploratory behavior and balance in juvenile rats, and mixed stress reverses these effects. Stress 2017; 20: 320-328.##Barzegar M, Sajjadi FS, Talaei SA, Hamidi G, Salami M. Prenatal exposure to noise stress: Anxiety, impaired spatial memory, and deteriorated hippocampal plasticity in postnatal life. Hippocampus 2015; 25: 187-96.##Basner M, Babisch W, Davis A, Brink M, Clark C, Janssen S, et al. Auditory and non-auditory effects of noise on health. Lancet 2014; 383: 1325-32.##Cheng L, Wang SH, Chen QC, Liao XM. Moderate noise induced cognition impairment of mice and its underlying mechanisms. Physiol Behav 2011; 104: 981-8.##Clark C, Crombie R, Head J, van Kamp I, van Kempen E, Stansfeld SA. Does traffic-related air pollution explain associations of aircraft and road traffic noise exposure on children's health and cognition? A secondary analysis of the united kingdom sample from the ranch project. Am J Epidemiol 2012; 176: 327-37.##Cui B, Wu M, She X. Effects of chronic noise exposure on spatial learning and memory of rats in relation to neurotransmitters and nmdar2b alteration in the hippocampus. J Occup Health 2009; 51: 152-8.##Cui B, Wu M, She X, Liu H. Impulse noise exposure in rats causes cognitive deficits and changes in hippocampal neurotransmitter signaling and tau phosphorylation. Brain Res 2011; 1427: 35-43.##Eichenbaum H. The hippocampus and declarative memory: Cognitive mechanisms and neural codes. Behav Brain Res 2001; 127: 199-207.##Eraslan E, Akyazi I, Erg LEE, Matur E. Noise stress changes mrna expressions of corticotropin-releasing hormone, its receptors in amygdala, and anxiety-related behaviors. Noise Health 2015; 17: 141-7.##Evans G, Higge S. Noise and performance in adults  and children. London: Whurr Publ, 2010.##Gorchetchnikov A, Grossberg S. Space, time and learning in the hippocampus: How fine spatial and temporal scales are expanded into population codes for behavioral control. Neural Netw 2007; 20: 182-93.##Haines MM, Brentnall SL, Stansfeld SA, Klineberg E. Qualitative responses of children to environmental noise. Noise Health 2003; 5: 19-30.##Ising H, Braun C. Acute and chronic endocrine effects of noise: Review of the research conducted at the institute for water, soil and air hygiene. Noise Health 2000; 2: 7-24.##Jian Goa Y, Yang X, Sheng-Jun D, Guang-Zhan F, Hua G, De-Zhong Y. Enhancement of spatial learning memory in developing rats via mozart music. Journal of Electronic Science and Technology of China 2009; 7: 47-49.##Kim H, Lee MH, Chang HK, Lee TH, Lee HH, Shin MC, et al. Influence of prenatal noise and music on the spatial memory and neurogenesis in the hippocampus of developing rats. Brain Dev 2006; 28: 109-14.##Kujawa SG, Liberman MC. Synaptopathy in the noise-exposed and aging cochlea: Primary neural degeneration in acquired sensorineural hearing loss. Hear Res 2015; 330: 191-9.##Liu L, Shen P, He T, Chang Y, Shi L, Tao S, et al. Noise induced hearing loss impairs spatial learning/memory and hippocampal neurogenesis in mice. Vol 6: Nature Publishing Group, 2016: 20374.##Manikandan S, Padma MK, Srikumar R, Jeya Parthasarathy N, Muthuvel A, Sheela Devi R. Effects of chronic noise stress on spatial memory of rats in relation to neuronal dendritic alteration and free radical-imbalance in hippocampus and medial prefrontal cortex. Neurosci Lett 2006; 399: 17-22.##Munzel T, Sorensen M, Schmidt FP, Schmidt E, Steven S, Kroller-Schon S, et al. The adverse effects of environmental noise exposure on oxidative stress and cardiovascular risk. Antioxid Redox Signal 2018; 28: 873-908.##Niemtzow RC. Loud noise and pregnancy. Mil Med 1993; 158: 10-2.##Nishio H, Tokumo K, Hirai T. Effects of perinatal stress on the anxiety-related behavior of the adolescence mouse. Int J Dev Neurosci 2006; 24: 263-8.##Oladehin A, Margret CP, Maier SE, Li CX, Jan TA, Chappell TD, et al. Early postnatal alcohol exposure reduced the size of vibrissal barrel field in rat somatosensory cortex (si) but did not disrupt barrel field organization. Alcohol 2007; 41: 253-61.##Prior H. Effects of predictable and unpredictable intermittent noise on spatial learning in rats. Behav Brain Res 2002; 133: 117-24.##Roozendaal B. Stress and memory: Opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 2002; 78: 578-95.##Saberi Moghadam A, Sepehri G, Sheibani V, Haghpanah T, Divsalar K, Hajzadeh MA, et al. The effect of opium dependency of parent (s) on offspring's spatial learning &#38; memory in adult male rats. Iran J Basic Med Sci 2013; 16: 694-9.##Sepehri G, Parsania S, Hajzadeh MA, Haghpanah T, Sheibani V, Divsalar K, et al. The effects of co-administration of opium and morphine with nicotine during pregnancy on spatial learning and memory of adult male offspring rats. Iran J Basic Med Sci 2014; 17: 694-701.##Tao S, Liu L, Shi L, Li X, Shen P, Xun Q, et al. Spatial learning and memory deficits in young adult mice exposed to a brief intense noise at postnatal age. J Otol 2015; 10: 21-28.##Toukh M, Gordon SP, Othman M. Construction noise induces hypercoagulability and elevated plasma corticosteroids in rats. Clin Appl Thromb Hemost 2014; 20: 710-5.##Tzivian L, Dlugaj M, Winkler A, Hennig F, Fuks K, Sugiri D, et al. Long-term air pollution and traffic noise exposures and cognitive function:A cross-sectional analysis of the heinz nixdorf recall study. J Toxicol Environ Health A 2016; 79: 1057-1069.##Xing Y, Chen W, Wang Y, Jing W, Gao S, Guo D, et al. Music exposure improves spatial cognition by enhancing the bdnf level of dorsal hippocampal subregions in the developing rats. Brain Res Bull 2016; 121: 131-7.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Changes in the levels of hippocampal BDNF expression are accompanied with inflammatory dental pain-induced learning and memory impairment</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Learning and memory requires a brain-derived neurotrophic factor (BDNF)-dependent phase in the hippocampus. It has been reported that chronic pain decreases hippocampal BDNF levels. We have also previously reported that noxious stimulation of the rat tooth pulp impairs learning and memory. Therefore, we decided to find the changes in the hippocampal BDNF expression which are associated with tooth pain and learning and memory impairment. Methods: Dental pulp nociception was induced by intradental injection of capsaicin (100&#956;g) in male Wistar rats. BDNF expression levels were determined by semi-quantitative RT-PCR and western blotting. Results: The data indicated that capsaicin elicited pain behaviors and impaired learning and memory in Morris water maze test. The protein and mRNA levels of BDNF were significantly (P&#60;0.05) decreased in capsaicin-treated rats as compared with control animals. Furthermore, iboprofen (120mg/kg, ip) treatment caused a significant (P&#60;0.05) up-regulation of the BDNF protein and mRNA in the hippocampus of capsaicin-injected animals. Conclusion: These findings suggest that inflammatory dental pain induces hippocampal function impairments by decreasing in BDNF expression.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>155</FPAGE>
			<TPAGE>162</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/102018/02/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/11/15
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/202018/08/2
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/5/11
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Saeed</Name>
				<MidName></MidName>
				<Family>Esmaeili-Mahani</Family>
				<NameE>Saeed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Esmaeili-Mahani</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>semahani@uk.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Raoof</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Raoof</FamilyE>
				<Organizations>
				<Organization>Endodontology Research Center, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>mraoof@kmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mehdi</Name>
				<MidName></MidName>
				<Family>Abbasnejad</Family>
				<NameE>Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abbasnejad</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>mabbas@uk.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mahdieh</Name>
				<MidName></MidName>
				<Family>Nourzadeh</Family>
				<NameE>Mahdieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nourzadeh</FamilyE>
				<Organizations>
				<Organization>Iranian Center for Endodontic Research, Research Institute of Dental Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>m_nourzadeh@sbmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Dental pain</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Learning and memory</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hippocampus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>BDNF expression</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Amirkhosravi L, Raoof M, Raoof R, Abbasnejad M, Esmaeili Mahani S, Ramezani M, et al. Is inflammatory pulpal pain a risk factor for amnesia? Iranian Journal of Veterinary Science and Technology. 2015; 6: 62-76.##Apkarian AV, Sosa Y, Krauss BR, Thomas PS, Fredrickson BE, Levy RE, et al. Chronic pain patients are impaired on an emotional decision-making task. Pain. 2004; 108: 129-36.##Binder DK, Scharfman HE. Mini review. Growth factors. 2004; 22: 123-31.##Chevaleyre V, Takahashi KA, Castillo PE. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci. 2006; 29: 37-76.##Chidiac JJ, Rifai K, Hawwa NN, Massaad CA, Jurjus AR, Jabbur SJ, et al. Nociceptive behaviour induced by dental application of irritants to rat incisors: a new model for tooth inflammatory pain. European Journal of Pain. 2002; 6: 55-67.##Croll S, Suri C, Compton D, Simmons M, Yancopoulos G, Lindsay R, et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience. 1999; 93: 1491-506.##Dick BD, Rashiq S. Disruption of attention and working memory traces in individuals with chronic pain. Anesth Anal 2007; 104: 1223-9.##Duric V, McCarson KE. Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. The Journal of Pain. 2006; 7: 544-55.##Duric V, McCarson KE. Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippocampus during inflammatory pain. Molecular Pain. 2007; 3: 32.##Khairova RA, Machado-Vieira R, Du J, Manji HK. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol. 2009; 12: 561-78.##Kooshki R, Abbasnejad M, Esmaeili-Mahani S, Raoof M. The role of trigeminal nucleus caudalis orexin 1 receptors in orofacial pain transmission and in orofacial pain-induced learning and memory impairment in rats. Physiol Behav. 2016; 157: 20-7.##Kozlovskiy SA, Vartanov AV, Nikonova EY, Pyasik MM, Velichkovsky BM. The cingulate cortex and human memory processe. Psychology in Russia: State of the art. 2012; 5: 231-243.##Kuhajda MC, Thorn BE, Klinger MR, Rubin NJ. The effect of headache pain on attention (encoding) and memory (recognition). Pain. 2002; 97: 213-21.##Leal SL, Yassa MA. Neurocognitive aging and the hippocampus across species. Trends in Neurosciences. 2015; 38: 800-12.##Lee E-G, Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Reports. 2009; 42: 239-44.##Leuner B, Gould E, Shors TJ. Is there a link between adult neurogenesis and learning? Hippocampus. 2006; 16: 216-24.##Li Y, Peng S, Wan C, Cao L, Li Y. Chronic pain impairs spatial learning and memory ability and down-regulates Bcl-2 and BDNF mRNA expression in hippocampus of neonatal rats. Zhonghua er ke za zhi= Chinese journal of pediatrics. 2005; 43: 444-8.##Linnarsson S, Björklund A, Ernfors P. Learning deficit in BDNF mutant mice. European Journal of Neuroscience. 1997; 9: 2581-7.##Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiology of learning and memory. 2008; 89: 312-23.##Lubin FD. Epigenetic gene regulation in the adult mammalian brain: multiple roles in memory formation. Neurobiology of learning and memory. 2011; 96: 68-78.##Macedo I, Rozisky J, Oliveira C, Oliveira C, Laste G, Nonose Y, et al. Chronic stress associated with hypercaloric diet changes the hippocampal BDNF levels in male Wistar rats. Neuropeptides. 2015; 51: 75-81.##Malcangio M, Lessmann V. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends in pharmacological sciences. 2003; 24: 116-21.##Moriarty O, Finn DP. Cognition and pain. Curr Opin Support Palliat Care. 2014; 8: 130-6.##Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011; 93: 385-404.##Mu J-S, Li W-P, Yao Z-B, Zhou X-F. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain research. 1999; 835: 259-65.##Petzold A, Psotta L, Brigadski T, Endres T, Lessmann V. Chronic BDNF deficiency leads to an age-dependent impairment in spatial learning. Neurobiology of Learning and Memory. 2015; 120: 52-60.##Pisu MG, Dore R, Mostallino MC, Loi M, Pibiri F, Mameli R, et al. Down-regulation of hippocampal BDNF and Arc associated with improvement in aversive spatial memory performance in socially isolated rats. Behavioural brain research. 2011; 222: 73-80.##Poo M. Neurotrophins as synaptic modulators. Nature Reviews Neuroscience. 2001; 2:  24-32.##Price TJ, Inyang KE. Chapter Fourteen-Commonalities Between Pain and Memory Mechanisms and Their Meaning for Understanding Chronic Pain. Progress in molecular biology and translational science. 2015; 131: 409-34.##Raoof M, Esmaeili-Mahani S, Nourzadeh M, Raoof R, Abbasnejad M, Amirkhosravi L, et al. Noxious stimulation of the rat tooth pulp may impair learning and memory through the induction of hippocampal apoptosis. J Oral Facial Pain Headache. 2015; 29: 390-7.##Rudge JS, Mather PE, Pasnikowski EM, Cai N, Corcoran T, Acheson A, et al. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective. Experimental neurology. 1998; 149: 398-410.##Saffarpour S, Shaabani M, Naghdi N, Farahmandfar M, Janzadeh A, Nasirinezhad F. In vivo evaluation of the hippocampal glutamate, GABA and the BDNF levels associated with spatial memory performance in a rodent model of neuropathic pain. Physiology &#38; Behavior. 2017; 175: 97-103.##Squire LR. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992; 99: 195.##Xu H-W, Li X-C, Li H-D, Ruan H-Z, Liu Z-Z. Effects of corticotrophin on pain behavior and BDNF, CRF levels in frontal cortex of rats suffering from chronic pain. Acta Pharmacologica Sinica. 2000; 21: 600-4.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of curcumin against 6-hydroxydopamine induced cell death and Akt/GSK disruption in human neuroblastoma cells</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Parkinson&#8217;s disease (PD) is the second most common neurodegenerative disease, characterized by the continuous deficit of dopaminergic neural cells in the substantia nigra pars compacta. The natural compounds from plant extracts, such as turmeric, have been proposed as alternative sources for anti-PD drugs. Human neuroblastoma SH-SY5Y is a dopaminergic neuronal cell line used as an in vitro model for the study of dopaminergic cells. The neurotoxin 6-hydroxydopamine (6-OHDA) has been known to induce cell death in dopaminergic neural cells. Curcumin, as the main ingredient of turmeric, has been shown to protect against some animal models of PD. The purpose of the present study was to assess the potential neuroprotective effect of curcumin against the 6-OHDA-induced cell death in SH-SY5Y cells and to delineate its effect on Akt/GSK-3&#946; signaling. Methods: The cells were exposed to 6-OHDA with/without different doses of curcumin and their viability was examined via MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) and morphological observations. According to the MTT results, the protective doses of curcumin (2 and 2.5&#956;M) were selected for further studies. Western blot assay was done to determine the phosphorylated and total amount of Akt and GSK-3&#946; proteins. Results: 6-OHDA induced cell death and declined Akt/GSK-3&#946; phosphorylation, while curcumin co-treatment partially restored these effects. Conclusion: Taken together, these findings suggest that curcumin protects the SH-SY5Y cells from 6-OHDA-induced cell death and Akt/GSK-3&#946; signaling alteration. Thus, our study indicates that curcumin has a partial cytoprotective effect in dopaminergic cell culture systems.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>163</FPAGE>
			<TPAGE>171</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/102018/02/42018/04/3
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/1/14
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/202018/08/22018/08/2
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/5/11
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Moosavi</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moosavi</FamilyE>
				<Organizations>
				<Organization>Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>marmoosavi@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Majid Reza</Name>
				<MidName></MidName>
				<Family>Farrokhi</Family>
				<NameE>Majid Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Farrokhi</FamilyE>
				<Organizations>
				<Organization>Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>farokhim@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Narges</Name>
				<MidName></MidName>
				<Family>Tafreshi</Family>
				<NameE>Narges</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tafreshi</FamilyE>
				<Organizations>
				<Organization>Department of Cancer Imaging and Metabolism, Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida 33612, USA</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>Narges.Tafreshi@moffitt.org</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Parkinson’s disease</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>6-OHDA</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>SH-SY5Y</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Curcumin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Akt</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>GSK-3β</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The indian solid gold. Adv Exp Med Biol 2007; 595: 1-75.##Amiri E, Ghasemi R, Moosavi M. Agmatine protects against 6-ohda-induced apoptosis, and erk and akt/gsk disruption in sh-sy5y cells. Cell Mol Neurobiol 2016; 36: 829-38.##Banerjee A, Kunwar A, Mishra B, Priyadarsini KI. Concentration dependent antioxidant/pro-oxidant activity of curcumin: Studies from aaph induced hemolysis of rbcs. Chemico-Biological Interactions 2008; 174: 134-139.##Bijur GN, De Sarno P, Jope RS. Glycogen synthase kinase-3β facilitates staurosporine-and heat shock-induced apoptosis protection by lithium. Journal of Biological Chemistry 2000; 275: 7583-7590.##Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J. Glycogen synthase kinase 3beta (gsk3beta) mediates 6-hydroxydopamine-induced neuronal death. Faseb j 2004; 18: 1162-4.##Cheung YT, Lau WK, Yu MS, Lai CS, Yeung SC, So KF, et al. Effects of all-trans-retinoic acid on human sh-sy5y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 2009; 30: 127-35.##Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three akts. Genes Dev 1999; 13: 2905-27.##Daverey A, Agrawal SK. Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes. Neuroscience 2016; 333: 92-103.##Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK. Gsk-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma neuro-2a cell line. Journal of Neuro-Oncology 2011; 104: 145-153.##Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3β regulates cyclin d1 proteolysis and subcellular localization. Genes and Development 1998; 12: 3499-3511.##Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of parkinson disease in advanced age. Neurology 2009; 72: 432-8.##Fan YL, Li HC, Zhao W, Peng HH, Huang F, Jiang WH, et al. Curcumin attenuated bupivacaine-induced neurotoxicity in sh-sy5y cells via activation of the akt signaling pathway. Neurochem Res 2016; 41: 2425-32.##Forno LS. Neuropathology of parkinson's disease. J Neuropathol Exp Neurol 1996; 55: 259-72.##FRAME S, COHEN P. Gsk3 takes centre stage more than 20 years after its discovery. Biochemical Journal 2001; 359: 1-16.##Franke TF, Cantley LC. Apoptosis. A bad kinase makes good. Nature 1997; 390: 116-7.##Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, et al. Apolipoprotein e polymorphism and alzheimer disease: The indo-us cross-national dementia study. Arch Neurol 2000; 57: 824-30.##Ghasemi R, Moosavi M, Zarifkar A, Rastegar K, Maghsoudi N. The interplay of akt and erk in abeta toxicity and insulin-mediated protection in primary hippocampal cell culture. J Mol Neurosci 2015; 57: 325-34.##Greene LA, Levy O, Malagelada C. Akt as a victim, villain and potential hero in parkinson's disease pathophysiology and treatment. Cell Mol Neurobiol 2011; 31: 969-78.##Guha S, Cullen JP, Morrow D, Colombo A, Lally C, Walls D, et al. Glycogen synthase kinase 3 beta positively regulates notch signaling in vascular smooth muscle cells: Role in cell proliferation and survival. Basic Research in Cardiology 2011; 106: 773-785.##Huang HC, Tang D, Xu K, Jiang ZF. Curcumin attenuates amyloid-beta-induced tau hyperphosphorylation in human neuroblastoma sh-sy5y cells involving pten/akt/gsk-3beta signaling pathway. J Recept Signal Transduct Res 2014; 34: 26-37.##Huang HC, Xu K, Jiang ZF. Curcumin-mediated neuroprotection against amyloid-beta-induced mitochondrial dysfunction involves the inhibition of gsk-3beta. J Alzheimers Dis 2012; 32: 981-96.##Hwang O. Role of oxidative stress in parkinson's disease. Exp Neurobiol 2013; 22: 11-7.##Jaisin Y, Thampithak A, Meesarapee B, Ratanachamnong P, Suksamrarn A, Phivthong-Ngam L, et al. Curcumin i protects the dopaminergic cell line sh-sy5y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis. Neurosci Lett 2011; 489: 192-6.##Jaroonwitchawan T, Chaicharoenaudomrung N, Namkaew J, Noisa P. Curcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy. Neurosci Lett 2017; 636: 40-47.##Khatri DK, Juvekar AR. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of parkinson's disease. Pharmacol Biochem Behav 2016; 150-151: 39-47.##Khopde SM, Priyadarsini KI, Guha SN, Satav JG, Venkatesan P, Rao MN. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: Possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem 2000; 64: 503-9.##Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba-Toriyama H, et al. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 1998; 19: 81-5.##Kim SJ, Son TG, Park HR, Park M, Kim MS, Kim HS, et al. Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 2008; 283: 14497-505.##Ljungdahl A, Hokfelt T, Jonsson G, Sachs C. Autoradiographic demonstration of uptake and accumulation of 3h-6-hydroxydopamine in adrenergic nerves. Experientia 1971; 27: 297-9.##Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.##Masuda T, Hidaka K, Shinohara A, Maekawa T, Takeda Y, Yamaguchi H. Chemical studies on antioxidant mechanism of curcuminoid: Analysis of radical reaction products from curcumin. J Agric Food Chem 1999; 47: 71-7.##Meesarapee B, Thampithak A, Jaisin Y, Sanvarinda P, Suksamrarn A, Tuchinda P, et al. Curcumin i mediates neuroprotective effect through attenuation of quinoprotein formation, p-p38 mapk expression, and caspase-3 activation in 6-hydroxydopamine treated sh-sy5y cells. Phytother Res 2014; 28: 611-6.##Morgante L, Morgante F, Moro E, Epifanio A, Girlanda P, Ragonese P, et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord 2007; 13: 528-31.##Negintaji K, Zarifkar A, Ghasemi R, Moosavi M. Humanin does not protect against stz-induced spatial memory impairment. J Mol Neurosci 2015; 56: 290-8.##Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008; 14: 458-70.##Rajeswari A, Sabesan M. Inhibition of monoamine oxidase-b by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of parkinson's disease induced by mptp neurodegeneration in mice. Inflammopharmacology 2008; 16: 96-9.##Schule B, Pera RA, Langston JW. Can cellular models revolutionize drug discovery in parkinson's disease? Biochim Biophys Acta 2009; 1792: 1043-51.##Shin S, Wolgamott L, Yu Y, Blenis J, Yoon SO. Glycogen synthase kinase (gsk)-3 promotes p70 ribosomal protein s6 kinase (p70s6k) activity and cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: E1204-E1213.##Song JX, Shaw PC, Wong NS, Sze CW, Yao XS, Tang CW, et al. Chrysotoxine, a novel bibenzyl compound selectively antagonizes mpp(+), but not rotenone, neurotoxicity in dopaminergic sh-sy5y cells. Neurosci Lett 2012; 521: 76-81.##Song S, Nie Q, Li Z, Du G. Curcumin improves neurofunctions of 6-ohda-induced parkinsonian rats. Pathol Res Pract 2016; 212: 247-51.##Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973; 25: 447-52.##Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 1994; 303 ( Pt 3): 701-4.##Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR. Inhibition of the hiv-1 and hiv-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1993; 1: 415-22.##Wang J, Du XX, Jiang H, Xie JX. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa b modulation in mes23.5 cells. Biochem Pharmacol 2009; 78: 178-83.##Wang K, Zhou F, Zhu X, Zhang K, Huang B, Zhu L, et al. Neuroprotective properties of ciliary neurotrophic factor on retinoic acid (ra)-predifferentiated sh-sy5y neuroblastoma cells. Folia Neuropathol 2014; 52: 121-7.##Wang MS, Boddapati S, Emadi S, Sierks MR. Curcumin reduces α-synuclein induced cytotoxicity in parkinson's disease cell model. BMC Neuroscience 2010; 11: 57-57.##Wang X-S, Zhang Z-R, Zhang M-M, Sun M-X, Wang W-W, Xie C-L. Neuroprotective properties of curcumin in toxin-base animal models of parkinson’s disease: A systematic experiment literatures review. BMC Complementary and Alternative Medicine 2017a; 17: 412.##Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL. Neuroprotective properties of curcumin in toxin-base animal models of parkinson's disease: A systematic experiment literatures review. BMC Complement Altern Med 2017b; 17: 412.##Watcharasit P, Bijur GN, Song L, Zhu J, Chen X, Jope RS. Glycogen synthase kinase-3beta (gsk3beta) binds to and promotes the actions of p53. The Journal of biological chemistry 2003; 278: 48872-48879.##Xing C, Peng Y, Chang R, Yin Y, Xie Z. Effects of insulin-like growth factor-1 on okadaic acid-induced apoptosis in sh-sy5y cells. Cell Biol Int 2005; 29: 803-8.##Yin W, Zhang X, Li Y. Protective effects of curcumin in appswe transfected sh-sy5y cells. Neural Regen Res 2012; 7: 405-12.##Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-ohda model of parkinson's disease. Free Radic Res 2005; 39: 1119-25.#### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effects of rapamycin on the symptoms of cerebral ischemia due to changing the expression of miR-1 and its target genes, Bad and Bcl-w</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Stroke is the major cause of long-term disability in adults. The precise role of the mTOR signaling pathway in neural viability due to rapamycin effect in the animal model of middle cerebral artery occlusion (MCAO) remained elusive. Since the relationship between mTOR and miR-1, especially in neurons, is unknown, we have evaluated the effect of rapamycin as a post-ischemic treatment on improving stroke symptoms. Methods: Rats were divided into three groups including sham, control and rapamycin treatment group. Each contains four subgroups (n=7). One hour after MCAO, rats were received intravenously 0.1ml normal saline or 0.1ml rapamycin in the control and treatment groups, respectively. After 24 hours, neurologic deficit score, infarct volume, brain edema, and blood-brain barrier (BBB) permeability were measured in the control and treatment group. The expression of miR-1, Bcl-w and Bad were analyzed using quantitative RT-PCR in all groups. Results: Our results indicate that post-treatment with rapamycin, significantly reduces neurological deficits, infarct volume, brain edema and BBB permeability. It also decreases the level of miR-1 and Bad expression and increases the level of Bcl-w expression. Conclusion: According to our findings, post-ischemic treatment with rapamycin can be effective in improving symptoms of stroke using changing in the expression of the miR-1 gene and consequently, a changing in the expression of the target genes of this miRNA (i.e., Bad and Bcl-w). In summary, we unravel for the first time a link between mTOR, miRNA-1, Bcl-w and Bad in brain ischemia.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>172</FPAGE>
			<TPAGE>182</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/102018/02/42018/04/32018/04/13
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/1/24
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/202018/08/22018/08/22018/08/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/6/6
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Anis</Name>
				<MidName></MidName>
				<Family>Talebi</Family>
				<NameE>Anis</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Talebi</FamilyE>
				<Organizations>
				<Organization>Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mehdi</Name>
				<MidName></MidName>
				<Family>Rahnema</Family>
				<NameE>Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rahnema</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Islamic Azad University-Zanjan Branch, Zanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>Mehdi.rahnema@iauz.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad reza</Name>
				<MidName></MidName>
				<Family>Bigdeli</Family>
				<NameE>Mohammad reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bigdeli</FamilyE>
				<Organizations>
				<Organization>Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>mr_bigdeli@sbu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>miR-1 antagomir</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Stroke</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Bad</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Bcl-w</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rapamycin</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Bansal S, Sangha KS, Khatri P. Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs. 2013; 13(1):57-69.##Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116: 281 297.##Bigdeli MR, Hajizadeha S, Froozandeh M, Rasulian B, Heidarianpour A, et al. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 2007;1152:228-33. a##Bigdeli MR, Sohrab Hajizadeh S, Froozandeh M, Heidarianpour A, Rasulian B, et al. Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-α level. Experimental Neurology. 2008; 212: 298–306. b##Bochelen D, Rudin M, Sauter A. Calcineurin inhibitors FK506 and SDZ ASM##981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol##Exp Ther.1999; 288(2):653-9.##Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle. 2007; 6: 2127 2132.##Castedo  M,  Ferri KF,  Kroemer G. Mammalian Target of Rapamycin (mTOR): Pro- and##Anti-Apoptotic. Cell Death and Differentiation. 2002; 9, 99 – 100.##CH Jing, L Wang, PP Liu, C Wu, D Ruan, G Chen. Autophagy activation is associated with neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage. Neuroscience. 2012; 213: 144–153.##Chauhan A, Sharma U, Jagannathan NR,  Reeta K H, Gupta Y K. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res. 2011; 225(2):603-9.##Datta, S R, Dudek H, Tao X, Masters SH, Fu H, Gotoh Y. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;   91: 231–241.##Delft M F V, Huang D C S. How the Bcl‑2 family of proteins interact to regulate apoptosis. Cell Research. 2006; 16: 203-213.##Dharap A and Vemuganti R. Ischemic pre conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem. 2010; 113: 1685 1691.a##Dharap A, Bowen K, Place R, Li L CH, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral MicroRNAome. Journal of Cerebral Blood Flow and Metabolism .2009; 29(4): 675–687.b ##Dhodda VK, Sailor KA, Bowen KK, Vemuganti R, et al. Putative endogenous mediators of preconditioning induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem. 2004; 89: 73 89. ##Dirnagl U, Becker K and Meisel A. Preconditioning and tolerance against cerebral ischemia: from experimental strategies to clinical use. Lancet Neurol. 2009; 8: 398 412.##Eerlish S, Alexandrovich A, Shohami E, Pinkas-kermarski R. Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis. 2007; 26(1):86-93.##Fletcher L, Evans TM, Watts LT, Jimenez D F, Digicaylioglu M. Rapamycin treatment improves neuron viability in an in vitro model of stroke. PLoS One .2014; 4; 8(7).##Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem. 2010.285: 14071–14077.## ##Peirtti F, Lopez S, Bonardo B, Vague I J, Nalbone G.  Inhibition of p70S6 Kinase during Transforming Growth Factor-β1/Vitamin D3-induced Monocyte Differentiation of HL-60 Cells Allows Tumor Necrosis Factor-α to Stimulate Plasminogen Activator Inhibitor-1 Synthesis. J. Biol. Chem. 2001; 24;276(34):32214-9.##H´ebert  S S, Horr´e K, Nicola¨ı  L, Papadopoulou A S, Mandemakers W,  Silahtaroglu A N, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/𝛽-secretase expression. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(17): 6415–6420.##Hailer NP. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol. 2008; 84: 211–233.##Hisashi H, Jens S A, Matthias M, Trada N,  Korsmeyer S J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl. Acad. Sci. 2001; 98(17): 9666–9670.##Huang S, Liu LN, Hosoi H,  Dilling M B,  Shikata T, Houghton P J. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Cancer Res. 2001; 61(8):3373-81.##Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 2008; 39##(3):959–966.##Jin C, Zhao Y, Yu L, Xu S, Fu G, et al. MicroRNA-21 mediates the rapamycin-induced suppression of endothelial proliferation and migration. FEBS Lett .2013; 587(4):378-85.##Kim J, Inoue K, Ishii J, Vanti W B,  Voronov S V, Murchison E, et al. A microRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317 (5842): 1220–1224.##Kloosterman W P, Plasterk R H A. The diverse functions of MicroRNAs in animal development and disease. Developmental Cell. 2006; 11(4):441–450.##Kocerha J, Kauppinen S, Wahlestedt C. microRNAs in CNS disorders. Neuromolecular Med 2009; 11: 162 172.##Kuhn D E, Nuovo G J, Martin M M, Malana G E, Pleister A P, Jiang J, et al. Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochemical and Biophysical Research Communications. 2008; 370(3):473–477.##Lee S T, Chu K, Jung K-H, Yoon H-J, Jeon D, Kang K-M, et al. MicroRNAs induced during ischemic preconditioning. Strok.e 2010; 41: 1646 1651.##Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M,  Dai S, et al. heart disease and stroke statistics. American Heart  Association. Circulation. 2010; 121: 948–954.##Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20(1):84-91.##Lusardi TA, Farr CD, Faulkner CL, Yoon H-J, D  Jeon,  Kang K-M, et al. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab 2010; 30: 744 756.##Ma T, Hoeffer C A, Capetillo-Zarate E, Yu F, Wong H,  Lin M, et al. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer’s disease. PLoS One. 2010; 20: 5(9). ##Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S,  Greene L A. Rapamycin protects against neuron death  in vitro and in vivo models of Parkinson's disease. J Neurosci.2010; 30(3):1166-75.##Martin EC, Rhodes LV, Elliott S, Krebs A E, Nephew K P, Flemington E K, et al. microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity. Mol Cancer. 2014; 6;13:229.##Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer– new paradigms in molecular oncology. Curr Opin Cell Biol. 2009; 21:470–479.##Okouchi M, Ekshyyan O, Maracine M, Aw T Y. Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal. 2007; 9:1059–1096.##Ouyang Y B, Giffard R G. microRNAs affect BCL-2 family proteins in the setting of cerebral ischemia. Neurochem Int.  2014; 77:2-8.##Parsons RG, Gafford GM, Helmstetter FJ.  Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons.J Neurosci. 2006; 26:12977-12983.##Qin L, Lu G, Lijie H, Ruan L, Yang J, Huang W, et al. Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat. J Neuroinflammation .2014; 11: 44.##R Gong, CS Park, NR Abbassi, SJ Tang. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem. 2006: 281:18802-18815.##Santos RX, Correia SC, Cardoso S, Carvalho C, Santos M S, et al. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease. J Neurochem. 2011; 117(6):927-36.##Selvamani A, Sathyan P, Miranda R C, Sohrabji F . An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model. PLoS One. 2012; 7(2):e32662. ##Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of##FK506 in focal cerebral ischemia. Nature.1994 ; 371(6495):336-9.##Shi Y,  Frankel A, Radvanyi L G,  Penn L Z,  Miller R G, Mills G B. Rapamycin Enhances Apoptosis and Increases Sensitivity to Cisplatin in Vitro. Cancer Res. 1995; 55, 1982-1988.##Sun Y, Ge Y, Drnevich J,  Zhao Y,  Band M,  Chen J, et al. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J Cell Biol. 2010; 189(7):1157-69.##Tan KS, Armugam A, Sepramaniam S, Lim K Y, Setyowati K D, Wang CH W, et al. Expression profile of MicroRNAs in young stroke patients. PLoS One. 2009; 4(11): e7689.##Tang Y, Zheng j, Sun Y, Wu Z, Liu Z, Huang G, et al. MicroRNA-1 Regulates cardiomyocyte Apoptosis by Targeting Bcl-2. Int Heart J. 2009; 50(3):377-87.##Towfighi A, Saver JL. Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke. 2011; 42: 2351–2355.##Wang C, Ji B, Cheng B, Chen J, Bai B. Neuroprotection of microRNA in neurological disorders (Review). Biomed Rep 2014; 2(5):611-619.##Wang X, Zhang X, Ren X P, Chen I, Liu H,  Yang J, et al. MicroRNA-494 Targeting both Pro-apoptotic and Anti-apoptotic Proteins Protects against Ischemia/Reperfusion-Induced Cardiac Injury. Circulation. 2010;  122(13): 1308–1318.##Woltman A M,  de Fijter J W, Kamerling S W A,  Kooij S W V,  Paul L C,  Daha M R, et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood. 2001; 98:174-180. ##Yang W, Yongting W, Yang G-Y. MicroRNAs in Cerebral Ischemia. Stroke Research and Treatment.  2013; 276540. 6 pages. doi: 10.1155/2013/276540.##Yin L, Ye S, Chen Z, Zeng Y. Rapamycin preconditioning attenuates transient focal cerebral ischemia/reperfusion injury in mice. Int J Neurosci. 2012; 122(12):748-56.##Zhao Y, Ransom JF, Li A, Vedantham V, Drehle M V, Muth A N, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA 1 2. Cell. 2007.129: 303 317. ##Zhao Z C, Yan C S, Lijie Z, Wang S, Maiese K. Mammalian target of rapamycin: Hitting the bull’s-eye for neurological disorders. Oxidative Medicine and Cellular Longevity. 2010; 3:6, 374-391.#### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Anti-cancer properties of the methanol extract of Boswellia serrata gum resin: Cell proliferation arrest and inhibition of angiogenesis and metastasis in BALB/c mice breast cancer model</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Boswellia serrata is a medicinal plant with immense potential in combating cancer. Since many cancers therapeutics have their roots in natural products, we investigated the inhibitory effect of B. serrata gum resin alcoholic extract (BSE) on tumor growth, metastasis and angiogenesis in 4T1 breast cancer mouse model. Methods: Cell viability of BSE on triple negative cancer cell line, 4T1, was measured by MTT assay. In the anti-breast cancer study, female BALB/c mice in four groups (n=5) were implanted into the mammary fat pad with 4T1 cells (1&#215;105 cells/0.1 ml) and treated by BSE (50, 150 and 250mg/kg) and distilled water for 21 days. Anti-proliferation and anti-angiogenesis effects of BSE in tumor tissues were evaluated by immunohistochemical (IHC) analysis for Ki-67 and CD31 expression. The metastatic rate was investigated in the liver and lung tissues by histopathological analysis. Results: In in-vitro toxicity study, 4T1 cells line were sensitive to BSE treatment with reduced cell viability. BSE suppression of 4T1 tumor growth correlated with reduced cell proliferation as revealed by IHC analysis for Ki-67 expression. Analyses of the vasculature in the tumor tissues indicated smaller vessel area in BSE250 group compared to control tumors based on IHC for angiogenesis marker CD31. BSE only significantly decreased the metastatic rate in the lung tissue. Conclusion: From the outcome of our investigation, it is possible to conclude that BSE induces cell-specific cytotoxicity and suppresses cell proliferation, angiogenesis and metastasis rate in breast cancer cells and can be effective for advanced breast cancer.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>183</FPAGE>
			<TPAGE>194</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/102018/02/42018/04/32018/04/132018/07/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/4/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/202018/08/22018/08/22018/08/282018/08/25
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/6/3
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Hiva</Name>
				<MidName></MidName>
				<Family>Alipanah</Family>
				<NameE>Hiva</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alipanah</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>h_alipanah@sbu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Parvin</Name>
				<MidName></MidName>
				<Family>Zareian</Family>
				<NameE>Parvin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zareian</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>p.zareian@ajaums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Boswellia serrata</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cell proliferation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cytotoxicity</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Tumor Growth</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Breast Cancer</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Agrawal, S., Saraswati, S., Mathur, R., &#38; Pandey, M. Antitumor properties of Boswellic acid against Ehrlich ascites cells bearing mouse. Food and chemical toxicology,2011;49(9), 1924-1934. ##Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., &#38; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences,2003; 100(7), 3983-3988. ##Ammon, H. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wiener medizinische Wochenschrift (1946),2002; 152(15-16), 373-378. ##Arpornsuwan, T., &#38; Punjanon, T. Tumor cell‐selective antiproliferative effect of the extract from Morinda citrifolia fruits. Phytotherapy Research,2006; 20(6), 515-517. ##Betancur-Galvis, L. A., Saez, J., Granados, H., Salazar, A., &#38; Ossa, J. E. Antitumor and antiviral activity of Colombian medicinal plant extracts. Memórias do Instituto Oswaldo Cruz,1999; 94(4), 531-535. ##Bhushan, S., Kumar, A., Malik, F., Andotra, S. S., Sethi, V. K., Kaur, I. P., . . . Singh, J. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells. Apoptosis, 2007; 12(10), 1911-1926. ##Chashoo, G., Singh, S. K., Sharma, P. R., Mondhe, D. M., Hamid, A., Saxena, A., . . . Taneja, S. C. A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I &#38; II inhibition. Chemico-biological interactions,2011; 189(1-2), 60-71. ##Conti, S., Vexler, A., Edry-Botzer, L., Kalich-Philosoph, L., Corn, B. W., Shtraus, N., . . . Marmor, S. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells. PLoS One, 2018; 13(7), e0198627. ##Dholwani, K., Saluja, A., Gupta, A., &#38; Shah, D. A review on plant-derived natural products and their analogs with anti-tumor activity. Indian journal of pharmacology,2008; 40(2), 49. ##Ernst, E. (2008). Frankincense: systematic review. Bmj, 337, a2813. ##Etzel, R. Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis. Phytomedicine, 1996; 3(1), 91-94. ##Flavin, D. F. A lipoxygenase inhibitor in breast cancer brain metastases. Journal of neuro-oncology,2007; 82(1), 91-93. ##Folkman, J. The role of angiogenesis in tumor growth. Paper presented at the Seminars in cancer biology.1992.##Frank, M. B., Yang, Q., Osban, J., Azzarello, J. T., Saban, M. R., Saban, R., . . . Lin, H.-K. Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complementary and Alternative Medicine,2009; 9(1), 6. ##Gandhi, T., Gandhi, K., &#38; Monapara, K. Evaluation of Anti-cancer activity of Boswellic acid and Montelukast sodium against human prostate cancer cell line PC-3. Iranian Journal of Pharmaceutical Sciences,2016; 12(4), 15-32. ##Glaser, T., Winter, S., Groscurth, P., Safayhi, H., Sailer, E., Ammon, H., . . . Weller, M. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. British journal of cancer,1999; 80(5-6), 756. ##Hoernlein, R., Orlikowsky, T., Zehrer, C., Niethammer, D., Sailer, E., Simmet, T., . . . Ammon, H. Acetyl-11-keto-β-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. Journal of Pharmacology and Experimental Therapeutics,1999; 288(2), 613-619. ##Huang, G., Yang, J., Zhang, L., Cao, L., Zhang, M., Niu, X., . . . Liu, J. F. Inhibitory effect of 11-carbonyl-beta-boswellic acid on non-small cell lung cancer H446 cells. Biochemical and biophysical research communications. 2018.##Huang, M.-T., Liu, Y., Badmaev, V., &#38; Ho, C.-T. Inhibition of Inflammation, Expression of Pro-inflammatory Cytokines, Formation of Leukotriene B4 and Tumor Promotion in Mouse Skin by Boswellia serrata Extracts: ACS Publications, 2008.##Jing, Y., Nakajo, S., Xia, L., Nakaya, K., Fang, Q., Waxman, S., &#38; Han, R. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leukemia research,1999; 23(1), 43-50. ##Kunnumakkara, A. B., Nair, A. S., Sung, B., Pandey, M. K., &#38; Aggarwal, B. B. Boswellic acid blocks STAT3 Signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Molecular cancer research: MCR,2009; 7(1), 118. ##Leek, R., Landers, R., Harris, A., &#38; Lewis, C. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. British journal of cancer,1999; 79(5-6), 991. ##Liu, J.-J., Nilsson, A., Oredsson, S., Badmaev, V., &#38; Duan, R.-D. Keto-and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. International journal of molecular medicine,2002;  10(4), 501-505. ##Liu, J.-J., Nilsson, Å., Oredsson, S., Badmaev, V., Zhao, W.-Z., &#38; Duan, R.-D. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis,2002; 23(12), 2087-2093. ##Mazzio, E. A., Lewis, C. A., &#38; Soliman, K. F. Transcriptomic Profiling of MDA-MB-231 Cells Exposed to Boswellia Serrata and 3-O-Acetyl-B-Boswellic Acid; ER/UPR Mediated Programmed Cell Death. Cancer Genomics-Proteomics,2017; 14(6), 409-425. ##Morioka, H., Weissbach, L., Vogel, T., Nielsen, G. P., Faircloth, G. T., Shao, L., &#38; Hornicek, F. J. Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clinical Cancer Research,2003; 9(3), 1211-1217. ##Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., . . . Wagner, S. N. Involvement of chemokine receptors in breast cancer metastasis. nature, 2001; 410(6824), 50. ##Pang, X., Yi, Z., Zhang, X., Sung, B., Qu, W., Lian, X., . . . Liu, M. Acetyl-11-keto-β-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2–mediated angiogenesis. Cancer research,2009; 69(14), 5893-5900. ##Park, B., Prasad, S., Yadav, V., Sung, B., &#38; Aggarwal, B. B. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. PLoS One,2011; 6(10), e26943. ##Park, Y. S., Lee, J. H., Harwalkar, J. A., Bondar, J., Safayhi, H., &#38; Golubic, M. Acetyl-11-Keto-ß-Boswellic Acid (Akba) is Cytotoxic for Meningioma Cells and Inhibits Phosphorylation of the Extracellular-Signal Regulated Kinase 1 and 2 Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury,2002; 5 (pp. 387-393): Springer.##Pathania, A. S., Wani, Z. A., Guru, S. K., Kumar, S., Bhushan, S., Korkaya, H., . . . Ahmed, Z. The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors. Molecular cancer,2015; 14(1), 6. ##Pulaski, B. A., &#38; Ostrand‐Rosenberg, S. Mouse 4T1 breast tumor model. Current protocols in immunology,2000; 39(1), 20.22. 21-20.22. 16. ##Ranjbarnejad, T., Saidijam, M., Moradkhani, S., &#38; Najafi, R. Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells. Prostaglandins &#38; other lipid mediators, 2017; 131, 1-8. ##Roy, N. K., Deka, A., Bordoloi, D., Mishra, S., Kumar, A. P., Sethi, G., &#38; Kunnumakkara, A. B. The potential role of boswellic acids in cancer prevention and treatment. Cancer letters,2016; 377(1), 74-86. ##Shao, Y., Ho, C.-T., Chin, C.-K., Badmaev, V., Ma, W., &#38; Huang, M.-T. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta medica,1998; 64(4), 328-331. ##Siddiqui, M. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian journal of pharmaceutical sciences,2011; 73(3), 255. ##Streffer, J., Bitzer, M., Schabet, M., Dichgans, J., &#38; Weller, M. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology,2001; 56(9), 1219-1221. ##Suhail, M. M., Wu, W., Cao, A., Mondalek, F. G., Fung, K.-M., Shih, P.-T., . . . Lin, H.-K. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complementary and Alternative Medicine,2001; 11(1), 129. ##Syrovets, T., Gschwend, J. E., Büchele, B., Laumonnier, Y., Zugmaier, W., Genze, F., &#38; Simmet, T. Inhibition of IκB kinase activity by actyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. Journal of Biological Chemistry, 2004.##Thummuri, D., Jeengar, M. K., Shrivastava, S., Areti, A., Yerra, V. G., Yamjala, S., . . . Sistla, R. Boswellia ovalifoliolata abrogates ROS mediated NF-κB activation, causes apoptosis and chemosensitization in Triple Negative Breast Cancer cells. Environmental toxicology and pharmacology,2014;38(1), 58-70. ##Uddin, S. J., Grice, I. D., &#38; Tiralongo, E. Cytotoxic effects of Bangladeshi medicinal plant extracts. Evidence-Based Complementary and Alternative Medicine, 2011, 2011.##Wang, D., Ge, S., Bai, J., &#38; Song, Y. Boswellic acid exerts potent anticancer effects in HCT-116 human colon cancer cells mediated via induction of apoptosis, cell cycle arrest, cell migration inhibition and inhibition of PI3K/AKT signalling pathway. Journal of BU ON.: official journal of the Balkan :::union::: of Oncology,2018; 23(2), 340-345. ##Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., . . . Ribatti, D. Broad targeting of angiogenesis for cancer prevention and therapy. Paper presented at the Seminars in cancer biology, 2015.##Weigelt, B., Peterse, J. L., &#38; Van't Veer, L. J. Breast cancer metastasis: markers and models. Nature Reviews Cancer,2005; 5(8), 591-602. ##Xia, D., Lou, W., Fung, K.-M., Wolley, C. L., Suhail, M. M., &#38; Lin, H.-K. Cancer chemopreventive effects of Boswellia sacra gum resin hydrodistillates on invasive urothelial cell carcinoma: report of a case. Integrative cancer therapies,2017; 16(4), 605-611. ##Xia, L., Chen, D., Han, R., Fang, Q., Waxman, S., &#38; Jing, Y. Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells. Molecular cancer therapeutics,2005; 4(3), 381-388. ##Yadav, V. R., Prasad, S., Sung, B., Gelovani, J. G., Guha, S., Krishnan, S., &#38; Aggarwal, B. B. Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. International journal of cancer,2012; 130(9), 2176-2184. ##Zhang, Y., Ning, Z., Lu, C., Zhao, S., Wang, J., Liu, B., . . . Liu, Y. Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties. Chemistry Central Journal,2013; 7(1), 153. ##Zhao, W., Entschladen, F., Liu, H., Niggemann, B., Fang, Q., Zaenker, K. S., &#38; Han, R. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detection and prevention, 2003; 27(1), 67-75. ## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Inhibition of Candida albicans yeast– hyphal transition by combination of fluconazole with amphotericin B</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Candidiasis represents a major threat to the life and health in immune-compromised individuals. The number of antifungal drugs is limited for the treatment of candidiasis. Combination therapy is one of the most frequently used techniques to alleviate this problem. Methods: Clinical isolates of Candida albicans were obtained from the immune-compromised patients. Antifungal susceptibilities to fluconazole and amphotericin B alone and in combination were performed by broth microdilution method. Eventually direct microscopic observation, time-kill kinetic assay, biomass and metabolic activity of the hypha, Sap enzyme activity and expression of SAP3 gene were carried out in C. albicans. Results: Combination of fluconazole with amphotericin B demonstrated synergistic and partial synergistic effects with fractional inhibitory concentration index ranged from 0.031 to 0.75. The data indicated that combination of fluconazole with amphotericin B exerted antifungal effects through reducing time-kill kinetic, yeast&#8211; hyphal transition, biomass and metabolic activity of the hypha and Sap enzyme activity in C. albicans. Additionally, the expression levels of the SAP3 gene were significantly down regulated (P&#60;0.001) in C. albicans treated with combination of fluconazole with amphotericin B. Conclusion: Taken together, these events may confirm the potential uses of combination of fluconazole with amphotericin B against C. albicans. The results suggest that SAP3 gene could be probable target of synergistic interaction of fluconazole and amphotericin B in C. albicans.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>195</FPAGE>
			<TPAGE>204</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/102018/02/42018/04/32018/04/132018/07/42018/01/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/10/28
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/202018/08/22018/08/22018/08/282018/08/252018/09/3
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/6/12
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Alireza</Name>
				<MidName></MidName>
				<Family>Khodavandi</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khodavandi</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Gachsaran Branch, Islamic Azad University, Gachsaran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>khodavandi@iaug.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fahimeh</Name>
				<MidName></MidName>
				<Family>Alizadeh</Family>
				<NameE>Fahimeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alizadeh</FamilyE>
				<Organizations>
				<Organization>Department of Microbiology, Yasooj Branch, Islamic Azad University, Yasooj, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>f.alizadeh@iauyasooj.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Khezrian</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khezrian</FamilyE>
				<Organizations>
				<Organization>Department of Microbiology, Yasooj Branch, Islamic Azad University, Yasooj, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>f.Khezrian@iauyasooj.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Amphotericin B</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Candida albicans</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Fluconazole</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>SAP3</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Alizadeh F, Khodavandi A, Zalakian S. Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicans. Curr Med Mycol 2017; 3: 13-9.##Borelli C, Ruge E, Schaller M, Monod M, Korting HC, Huber R, et al. The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A. Proteins 2007; 68: 738–48. ##Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001; 9: 327–35.##Chin VK, Lee TY, Rusliza B, Chong PP. Dissecting Candida albicans infection from the perspective of C. albicans virulence and omics approaches on host–pathogen interaction: a review. Int J Mol Sci 2016; 17: E1643.##CLSI (Clinical and Laboratory Standards Institute). Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard M27-A3. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. ##Dalle F, Wächtler B, L'Ollivier C, Holland G, Bannert N, Wilson D, et al. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 2010; 12: 248–71.##Gray KC, Palacios DS, Dailey I, Endo ME, Uno BE, Wilcock BC, et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci 2012; 109: 2234–9.##Gu W, Guo D, Zhang L, Xu D, Sun S. The synergistic effect of azoles and fluoxetine against resistant Candida albicans strains is attributed to attenuating fungal virulence. Antimicrob Agents Chemother 2016; 60: 6179–88.##Haque F, Alfatah M, Ganesan K, Bhattacharyya MS. Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth. Sci Rep 2016; 6: 23575. ##Harmal NS, Khodavandi A, Alshawsh MA, Farida J, Sekawi Z, Ng K.P et al. Simplex and triplex polymerase chain reaction (PCR) for identification of three medically important Candida species. Afr J Biotechnol 2012; 11: 12895–902.##Hosseini SS, Yadegari MH, Rajabibazl M, Ghaemi EA. Inhibitory effects of carvacrol on the expression of secreted aspartyl proteinases 1-3 in fluconazole-resistant Candida albicans isolates. Iran J Microbiol 2016; 8: 401–9.##Khodavandi A, Alizadeh F, Aala F, Sekawi Z, Chong PP. In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida Species. Mycopathologia 2010; 169: 287–95.##Khodavandi A, Alizadeh F, Harmal NS, Sidik SM, Othman F, Sekawi Z, et al. Expression analysis of SIR2 and SAPs1-4 gene expression in Candida albicans treated with allicin compared to fluconazole. Trop Biomed 2011; 28: 589–98.##Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill curve results: proposed for standardized methods. Antimicrob Agents Chemother 1998; 42: 1207–12.##Lass-Flörl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs 2011; 71: 2405–19.##Lewis RE, Lund BC, Klepser ME, Ernst EJ, Pfaller MA. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. Antimicrob Agents Chemother 1998; 42: 1382–6.##Macdonald F, Odds FC. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol 1980; 13: 423–35. ##Mardani M, Badiee P, Gharibnavaz M, Jassebi A, Jafarian H, Ghassemi F. Comparison of anti-Candida activities of the ancient plants Lawsonia inermis and Ziziphus spina christi with antifungal drugs in Candida species isolated from oral cavity. J Conserv Dent 2018; 21: 359-62.##Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013; 4: 119–28.##Odds FC. Fluconazole plus amphotericin b combinations are not contraindicated and may add benefit for the treatment of candidemia. Clin Infect Dis 2003; 36: 1229–31. ##Paterson PJ, McWhinney PHM, Potter M, Kibbler CC, Prentice HG. The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients. Br J Haematol 2001; 112: 175–80.##Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 2008; 72: 157–65.##Pianalto KM, Alspaugh JA. New horizons in antifungal therapy. J Fungi (Basel) 2016; 2: pii: E26. ##Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 2003; 36: 1221–8. ##Ripeau JS, Aumont F, Belhumeur P, Ostrosky-Zeichner L, Rex JH, de Repentigny L. Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro. Antimicrob Agents Chemother 2002; 46: 3096–100.##Sharifynia S, Falahati M, Akhlaghi L, Foroumadi A, Fateh R. Molecular identification and antifungal susceptibility profile of Candida species isolated from patients with vulvovaginitis in Tehran, Iran. J Res Med Sci 2017; 22: 132. ##Shokohi T, Badali H, Amirrajab N, Ataollahi MR, Kouhpayeh SA, Afsarian MH. In vitro activity of five antifungal agents against Candida albicans isolates, Sari, Iran. Curr Med Mycol 2016; 2: 34-9. ##Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int 2013; 2013: 204237. ##Staniszewska M, Bondaryk M, Siennicka K, Kurek A, Orłowski J, Schaller M, et al. In vitro study of secreted aspartyl proteinases Sap1 to Sap3 and Sap4 to Sap6 expression in Candida albicans pleomorphic forms. Pol J Microbiol 2012; 61: 247–56. ##Sugar AM, Hitchcock CA, Troke PF,  Picard M. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob Agents Chemother 1995; 39: 598–601. ##Wu T, Wright K, Hurst SF, Morrison CJ. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in sub inhibitory concentrations of fluconazole. Antimicrob Agents Chemother 2000; 44: 1200–8.#### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The rate of resistance to tetracyclines and distribution of tetA, tetB, tetC, tetD, tetE, tetG, tetJ and tetY genes in Enterobacteriaceae isolated from Azerbaijan, Iran during 2017</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Enterobacteriaceae are the heterogeneous group of Gram-negative bacteria, which cause different infections. The incidence of resistance to antibiotics among the Enterobacteriaceae is growing. This study investigated antibiotic resistance features and tetracycline resistance genes distribution in Enterobacteriaceae isolates from Hospitals of Azerbaijan, Iran. Methods: The disc diffusion agar and agar dilution methods were used for assessment of antibiotics susceptibility patterns and minimum inhibitory concentration determination of tetracycline and minocycline. To detect eight tetracycline resistance genes (tetA, tetB, tetC, tetD, tetE, tetG, tetJ, and tetY), the PCR was performed in tetracycline-resistant isolates. Results: The resistance rate to tetracycline, minocycline, doxycycline, and tigecycline by the disc diffusion agar method were 58.8%, 24%, 43.6% and 0.4%, respectively. Fifty-one (20.4%) isolates were multiple drugs resistant. The minimum inhibitory concentration results showed 52% resistance to tetracycline and 22% for minocycline. The percentage of tet genes distribution was tetA (14.4%), tetB (18.4%), tetC (2%) and tetD (4.4%). However, tetE, tetG, tetJ and tetY genes were not detected in the present study. Conclusion: There is a moderate-high resistance rate to tetracycline among Enterobacteriaceae in Azerbaijan. The most effective antibiotic against Enterobacteriaceae was tigecycline followed by fosfomycin, imipenem and meropenem. The tet genes family especially tetA and tetB were prevalent among tetracycline-resistant isolates.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>205</FPAGE>
			<TPAGE>212</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2018/01/112018/02/102018/02/42018/04/32018/04/132018/07/42018/01/182018/03/24
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1397/1/4
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2018/09/202018/08/202018/08/22018/08/22018/08/282018/08/252018/09/32018/09/20
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1397/6/29
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Elham</Name>
				<MidName></MidName>
				<Family>Sheykhsaran</Family>
				<NameE>Elham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sheykhsaran</FamilyE>
				<Organizations>
				<Organization>Immunology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>Sheikhsarane@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hossein</Name>
				<MidName></MidName>
				<Family>Bannazadeh Baghi</Family>
				<NameE>Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bannazadeh Baghi</FamilyE>
				<Organizations>
				<Organization>Immunology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>hbannazadeh@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad Hossein</Name>
				<MidName></MidName>
				<Family>Soroush Barhaghi</Family>
				<NameE>Mohammad Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Soroush Barhaghi</FamilyE>
				<Organizations>
				<Organization>Immunology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>soroush@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Naser</Name>
				<MidName></MidName>
				<Family>Alizadeh</Family>
				<NameE>Naser</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alizadeh</FamilyE>
				<Organizations>
				<Organization>Students’ Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>Alizaden@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad Yousef</Name>
				<MidName></MidName>
				<Family>Memar</Family>
				<NameE>Mohammad Yousef</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Memar</FamilyE>
				<Organizations>
				<Organization>Students’ Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>memarm@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Shima</Name>
				<MidName></MidName>
				<Family>Etemadi</Family>
				<NameE>Shima</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Etemadi</FamilyE>
				<Organizations>
				<Organization>Students’ Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>Etemadish@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Reza</Name>
				<MidName></MidName>
				<Family>Ghotaslou</Family>
				<NameE>Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghotaslou</FamilyE>
				<Organizations>
				<Organization>Immunology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country></Country>
				</Countries>
				<EMAILS>
				<Email>gottasloreza@tbzmed.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Enterobacteriaceae</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Tetracyclines</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Suceptibility patterns</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>tet genes</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Akhi MT, Ghotaslou R, Memar MY, Asgharzadeh M, Varshochi M, Pirzadeh T, et al. Frequency of mrsa in diabetic foot infections. International Journal of Diabetes in Developing Countries 2017; 37: 58-62.##Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in jnmc hospital aligarh, india. Annals of clinical microbiology and antimicrobials 2007; 6: 4.##Aminov R, Chee-Sanford J, Garrigues N, Teferedegne B, Krapac I, White B, et al. Development, validation, and application of pcr primers for detection of tetracycline efflux genes of gram-negative bacteria. Applied and Environmental Microbiology 2002; 68: 1786-1793.##Aminov R, Garrigues-Jeanjean N, Mackie R. Molecular ecology of tetracycline resistance: Development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Applied and environmental microbiology 2001; 67: 22-32.##Andrews JM. Determination of minimum inhibitory concentrations. Journal of antimicrobial Chemotherapy 2001; 48: 5-16.##Chopra I, Roberts M. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and molecular biology reviews 2001; 65: 232-260.##Connell SR, Tracz DM, Nierhaus KH, Taylor DE. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrobial agents and chemotherapy 2003; 47: 3675-3681.##Control CfD, Prevention. Antibiotic resistance threats in the united states, 2013: Centres for Disease Control and Prevention, US Department of Health and Human Services, 2013.##Cunha B. Oral doxycycline for non-systemic urinary tract infections (utis) due to p. Aeruginosa and other gram negative uropathogens: Springer, 2012.##Deng M, Zhu M-H, Li J-J, Bi S, Sheng Z-K, Hu F-S, et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of acinetobacter baumannii from a chinese university hospital. Antimicrobial agents and chemotherapy 2014; 58: 297-303.##Fluit AC, Florijn A, Verhoef J, Milatovic D. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrobial agents and chemotherapy 2005; 49: 1636-1638.##Fritsche TR, Strabala PA, Sader HS, Dowzicky MJ, Jones RN. Activity of tigecycline tested against a global collection of enterobacteriaceae, including tetracycline-resistant isolates. Diagnostic microbiology and infectious disease 2005; 52: 209-213.##Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant enterobacteriaceae: Epidemiology and prevention. Clinical infectious diseases 2011; 53: 60-67.##Hansen DS, Aucken HM, Abiola T, Podschun R. Recommended test panel for differentiation of klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests. Journal of clinical microbiology 2004; 42: 3665-3669.##Hawkey P, Finch R. Tigecycline: In‐vitro performance as a predictor of clinical efficacy. Clinical microbiology and infection 2007; 13: 354-362.##Hirsch EB, Tam VH. Detection and treatment options for klebsiella pneumoniae carbapenemases (kpcs): An emerging cause of multidrug-resistant infection. Journal of Antimicrobial Chemotherapy 2010; 65: 1119-1125.##Hu L, Zhong Q, Shang Y, Wang H, Ning C, Li Y, et al. The prevalence of carbapenemase genes and plasmid-mediated quinolone resistance determinants in carbapenem-resistant enterobacteriaceae from five teaching hospitals in central china. Epidemiology &#38; Infection 2014; 142: 1972-1977.##Hudzicki J. Kirby-bauer disk diffusion susceptibility test protocol.  2009.##Hussain T, Jamal M, Nighat F, Andleeb S. Broad spectrum antibiotics and resistance in non-target bacteria: An example from tetracycline. J. Pure Appl. Microbiol 2014; 8: 2667-2671.##Jorgensen JH, Turnidge JD. Susceptibility test methods: Dilution and disk diffusion methods. Manual of clinical microbiology, eleventh edition: American Society of Microbiology, 2015: 1253-1273.##Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant enterobacteriaceae: A systematic review of the evidence from microbiological and clinical studies. Journal of Antimicrobial Chemotherapy 2008; 62: 895-904.##Kim Y-K, Pai H, Lee H-J, Park S-E, Choi E-H, Kim J, et al. Bloodstream infections by extended-spectrum β-lactamase-producing escherichia coli and klebsiella pneumoniae in children: Epidemiology and clinical outcome. Antimicrobial agents and chemotherapy 2002; 46: 1481-1491.##Kumar M. Colistin and tigecycline resistance in carbapenem-resistant enterobacteriaceae: Checkmate to our last line of defense. Infection Control &#38; Hospital Epidemiology 2016; 37: 624-625.##Livermore DM. Tigecycline: What is it, and where should it be used? Journal of Antimicrobial Chemotherapy 2005; 56: 611-614.##Miranda CD, Kehrenberg C, Ulep C, Schwarz S, Roberts MC. Diversity of tetracycline resistance genes in bacteria from chilean salmon farms. Antimicrobial agents and chemotherapy 2003; 47: 883-888.##Momtaz H, Rahimi E, Moshkelani S. Molecular detection of antimicrobial resistance genes in e. Coli isolated from slaughtered commercial chickens in iran. Veterinarni Medicina 2012; 57: 193-197.##Ng L-K, Martin I, Alfa M, Mulvey M. Multiplex pcr for the detection of tetracycline resistant genes. Molecular and cellular probes 2001; 15: 209-215.##Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. American journal of infection control 2006; 34: S20-S28.##Pournaras S, Vrioni G, Neou E, Dendrinos J, Dimitroulia E, Poulou A, et al. Activity of tigecycline alone and in combination with colistin and meropenem against klebsiella pneumoniae carbapenemase (kpc)-producing enterobacteriaceae strains by time–kill assay. International journal of antimicrobial agents 2011; 37: 244-247.##Ritchie DJ, Garavaglia-Wilson A. A review of intravenous minocycline for treatment of multidrug-resistant acinetobacter infections. Clinical Infectious Diseases 2014; 59: S374-S380.##Rohman A, Ijong F, Suwetja I. Viability of edwardsiella tarda and esherichia coli preserved with glycerol-tryptone soy broth (tsb) kept at freezing temperature. AQUATIC SCIENCE &#38; MANAGEMENT (Jurnal Ilmu dan Manajemen Perairan) 2013; 1: 154-159.##Ruzin A, Visalli MA, Keeney D, Bradford PA. Influence of transcriptional activator rama on expression of multidrug efflux pump acrab and tigecycline susceptibility in klebsiella pneumoniae. Antimicrobial agents and chemotherapy 2005; 49: 1017-1022.##Sadeghi MR, Ghotaslou R, Akhi MT, Asgharzadeh M, Hasani A. Molecular characterization of extended-spectrum β-lactamase, plasmid-mediated ampc cephalosporinase and carbapenemase genes among enterobacteriaceae isolates in five medical centres of east and west azerbaijan, iran. Journal of medical microbiology 2016; 65: 1322-1331.##Sloan B, Scheinfeld N. The use and safety of doxycycline hyclate and other second-generation tetracyclines. Expert opinion on drug safety 2008; 7: 571-577.##Stecher B, Denzler R, Maier L, Bernet F, Sanders MJ, Pickard DJ, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal enterobacteriaceae. Proceedings of the National Academy of Sciences 2012; 109: 1269-1274.##Tajbakhsh M, Hendriksen RS, Nochi Z, Zali MR, Aarestrup FM, Garcia-Migura L. Antimicrobial resistance in salmonella spp. Recovered from patients admitted to six different hospitals in tehran, iran from 2007 to 2008. Folia microbiologica 2012; 57: 91-97.##Tao R, Ying G-G, Su H-C, Zhou H-W, Sidhu JP. Detection of antibiotic resistance and tetracycline resistance genes in enterobacteriaceae isolated from the pearl rivers in south china. Environmental Pollution 2010; 158: 2101-2109.##Tuckman M, Petersen PJ, Howe AY, Orlowski M, Mullen S, Chan K, et al. Occurrence of tetracycline resistance genes among escherichia coli isolates from the phase 3 clinical trials for tigecycline. Antimicrobial agents and chemotherapy 2007; 51: 3205-3211.##Yadav KK, Adhikari N, Khadka R, Pant AD, Shah B. Multidrug resistant enterobacteriaceae and extended spectrum β-lactamase producing escherichia coli: A cross-sectional study in national kidney center, nepal. Antimicrobial resistance and infection control 2015; 4: 42.##Yezli S, Shibl AM, Livermore DM, Memish ZA. Prevalence and antimicrobial resistance among gram-negative pathogens in saudi arabia. Journal of chemotherapy 2014; 26: 257-272.##Zhang J, Stewart J. Economical and rapid method for extracting cotton genomic DNA. J Cotton Sci 2000; 4: 193-201.#### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
